
Shares of surgical factory operator Surgery Partners SGRY.O rise 3.8% to $23 after Q1 results
Co's Q1 revenue rises 8.2% to $776 mln from a year-ago
Adj. EBITDA up 6.6% to $103.9 mln
CFO Dave Doherty says Q1 results increase confidence to reaffirm FY guidance, amid uncertainty
Nine out of 12 analysts rate stock "buy" or higher, three "hold"; Median PT is $33 - LSEG
With session moves, SGRY up 9.4% YTD vs a 3.9% decline in the Nasdaq .IXIC